Facebook Linkedin RSS Twitter Youtube
Home 2023

Nucleosides

Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics
Insights

Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics

Christina Jackson -
0
How Oligonucleotide Therapeutics May Change the Course of Rare Diseases
Drug Discovery

How Oligonucleotide Therapeutics May Change the Course of Rare Diseases

Kathy Vuksanaj -
0
Custom ASOs Develop into Mass Producible Gene Therapies
Artificial Intelligence

Custom ASOs Develop into Mass Producible Gene Therapies

Jonathan D Grinstein, PhD -
0
Oligonucleotide Therapeutics: New Analytical Tools and Applications
Drug Discovery

Oligonucleotide Therapeutics: New Analytical Tools and Applications

Kathy Vuksanaj -
26
Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets
Drug Discovery

Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets

Jonathan D Grinstein, PhD -
20
First Alzheimer’s Disease Gene Silencing Approach Lowers Tau Levels in Humans
News

First Alzheimer’s Disease Gene Silencing Approach Lowers Tau Levels in Humans

Julianna LeMieux, PhD -
0
Antisense Oligonucleotides Help Treat Deadly Brain Cancer in Mice
Cancer

Antisense Oligonucleotides Help Treat Deadly Brain Cancer in Mice

Christina Jackson -
0
StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug
News

StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug

Alex Philippidis -
0
Stoked About ASOs: Stoke Therapeutics Treats Rare CNS Diseases With RNA-Based Medicines
GEN Edge

Stoked About ASOs: Stoke Therapeutics Treats Rare CNS Diseases With RNA-Based Medicines

Jonathan D Grinstein, PhD -
0
Manufacturing Novel Therapeutics
Learning Labs

Manufacturing Novel Therapeutics

Kathy Vuksanaj -
22
123...8Page 1 of 8
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.